Nabriva Therapeutics plc Share-based Payment Arrangement, Expense
Nabriva Therapeutics plc reported Share-based Payment Arrangement, Expense of $98.00 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2023-10-19
- Nabriva Therapeutics plc share-based payment arrangement, expense for the quarter ending 2023-06-30 was $98.00K, a 70.66% decline year-over-year.
- Nabriva Therapeutics plc share-based payment arrangement, expense for the quarter ending 2023-03-31 was $999.00K, a 0.10% decline year-over-year.
- Nabriva Therapeutics plc share-based payment arrangement, expense for the quarter ending 2022-12-31 was $135.00K, a 82.56% decline year-over-year.
- Nabriva Therapeutics plc share-based payment arrangement, expense for the quarter ending 2022-09-30 was $498.00K, a 36.07% decline year-over-year.
- Nabriva Therapeutics plc share-based payment arrangement, expense for fiscal 2022 was $1.97M, a 40.23% decline from fiscal 2021.
- Nabriva Therapeutics plc share-based payment arrangement, expense for fiscal 2021 was $3.29M, a 36.94% decline from fiscal 2020.
- Nabriva Therapeutics plc share-based payment arrangement, expense for fiscal 2020 was $5.22M, a 0.00% change from fiscal 2019.
- Nabriva Therapeutics plc share-based payment arrangement, expense for fiscal 2019 was $5.22M, a 1.26% increase from fiscal 2018.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2023-06-30 | $98.00K 10-Q · filed 2023-10-19 | $1.10M 10-Q · filed 2023-10-19 | $1.23M derived: sum of 3 quarters · filed 2023-10-19 | $1.73M derived: sum of 4 quarters · filed 2023-10-19 | |
| 2023-03-31 | $999.00K 10-Q · filed 2023-05-22 | $1.13M derived: sum of 2 quarters · filed 2023-05-22 | $1.63M derived: sum of 3 quarters · filed 2023-05-22 | $1.97M derived: sum of 4 quarters · filed 2023-10-19 | |
| 2022-12-31 | $135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $633.00K derived: sum of 2 quarters · filed 2023-04-17 | $967.00K derived: sum of 3 quarters · filed 2023-10-19 | $1.97M 10-K · filed 2023-04-17 | |
| 2022-09-30 | $498.00K 10-Q · filed 2022-11-10 | $832.00K derived: sum of 2 quarters · filed 2023-10-19 | $1.83M 10-Q · filed 2022-11-10 | $2.61M derived: sum of 4 quarters · filed 2023-10-19 | |
| 2022-06-30 | $334.00K 10-Q · filed 2023-10-19 | $1.33M 10-Q · filed 2023-10-19 | $2.11M derived: sum of 3 quarters · filed 2023-10-19 | $2.89M derived: sum of 4 quarters · filed 2023-10-19 | |
| 2022-03-31 | $1.00M 10-Q · filed 2023-05-22 | $1.77M derived: sum of 2 quarters · filed 2023-05-22 | $2.55M derived: sum of 3 quarters · filed 2023-05-22 | $3.37M derived: sum of 4 quarters · filed 2023-05-22 | |
| 2021-12-31 | $774.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $1.55M derived: sum of 2 quarters · filed 2023-04-17 | $2.37M derived: sum of 3 quarters · filed 2023-04-17 | $3.29M 10-K · filed 2023-04-17 | |
| 2021-09-30 | $779.00K 10-Q · filed 2022-11-10 | $1.60M derived: sum of 2 quarters · filed 2022-11-10 | $2.52M 10-Q · filed 2022-11-10 | $3.47M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $817.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $1.74M 10-Q · filed 2022-08-03 | $2.69M derived: sum of 3 quarters · filed 2022-08-03 | $3.92M derived: sum of 4 quarters · filed 2022-08-03 | |
| 2021-03-31 | $921.00K 10-Q · filed 2022-05-05 | $1.87M derived: sum of 2 quarters · filed 2022-05-05 | $3.10M derived: sum of 3 quarters · filed 2022-05-05 | ||
| 2020-12-31 | $953.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $2.18M derived: sum of 2 quarters · filed 2022-03-29 | $5.22M 10-K · filed 2022-03-29 | ||
| 2020-09-30 | $1.23M 10-Q · filed 2021-11-09 | $4.27M 10-Q · filed 2021-11-09 | |||
| 2019-12-31 | $5.22M 10-K · filed 2023-04-17 | $9.75M 10-K · filed 2020-03-12 | |||
| 2019-06-30 | $1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $3.73M 10-Q · filed 2019-08-08 | |||
| 2019-03-31 | $1.91M 10-Q · filed 2019-05-10 | ||||
| 2018-12-31 | $5.15M 10-K · filed 2021-03-11 | ||||
| 2018-06-30 | $767.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $2.01M 10-Q · filed 2019-08-08 | |||
| 2018-03-31 | $1.24M 10-Q · filed 2019-05-10 | ||||
| 2017-12-31 | $5.73M 10-K · filed 2020-03-12 | ||||
| 2016-12-31 | $2.54M 10-K · filed 2019-03-12 | ||||
| 2015-12-31 | $1.35M 10-K · filed 2018-03-16 |